Member Info for Jimzi

I sense the mms are moving many shares on no volume recenttly - trying to get interest for further falls imo. I feel something not quite right with many on this index and some hurt to come.

Agree on face value can't be bad. Its a special situations fund and this is just down their ally - high risk / high reward
Just how did it go through the market? - NEX vol v low as well.

Increased by 24.68m - yet add up the recent vol and it don't reconcile.
Could be LSE figures out but they still way out as not even accounting for autos and I'm assuming some pi buys - it wasn't 100% them.
If there is a foreign co selling that was already under 5%, then we won't know if a reduction of another sig holder.
And reporting is supposed to make things transparent !

Clearly the counter-party to these transactions doesn;t share the optimism here.
It could be as simple as a bod/shareholder clash/disagreement and a face off.

I'm merely pointing out its not a slam dunk metoric rise job. The chart is created by the director buys & the pi buying on the back of it - so hardly a true "market" analysis tool.

Well 1m absorbed and no ther selling atm.

You never know, could at market or a premium!

Deals are defo possible here - its down to the management to see if they can close - regulatory pressure is their unique opp.- watchlist for me

Could be - need more volume to confirm though

"Physicians prefer to use older, infinitely cheap antibiotics in their first response,"

But who is paying? And who is paying for the hospital visit in totum? How do you overcome the disconnect / conflict between what is in the best interests of the patient [ having a resistant AB] and the physician who goes for cheap. Why is the physician bothered about the cost - do they add in gross margins in the US?

I can't see insurers or patients opting for longer stays with older non resistant AB treatment when they have the alternative shown in the presentation.

In short, who are the real decision makers in the US re hospital treatment?

And we still have 6% shorts on IG! Most strange - hasn't moved for 6 months

Assume it says joint broker [not showing here]

Normally precursor to a placing I fear as the early sells point out.

I have no idea whats going on - nor does anyone else. But I still maintain it all looks too convienent - and the muted response seems to reflect this. [ non of this is a secret after all] AIM is too full of dodgy stuff - good luck and prob worth a small punt but the accounts - - esp balance sheer - means not for me.

the latest presentation uses hospital costs not drug costs as the case to be made.

What evidence?
Just as likely to get enough votes to go private - use the listing to raise and ditch when you have finished / alternatives

yes, but a $14m recoverable is in doubt and funding has raised its ugly head now. If the directors started selling , the company is finished as is their salary so not a terribly convincing argument imo [ I'm sure they have been reminded it would be inadvisable to sell if they even considered it]

I'm not averaging down atm until things become a little more clear.

All relative - depends on the ultimate reason and how much money he has.
I don't trust the accounts as per a message I posted sometime ago - so I'm suspicious - and its Africa!

TBH, the extent and frequency of these directors buys smacks of desparation to me - could be wrong but it all smells a bit fishy.

Yep, not too convinced by this 5% rise either - can't sell 200k at any price.

We knew it was long term!!

Yes, it removed one uncertainty to be replaced by another.

Considering how skittish AIM is atm, held up quite well imo. Could be a long winter though

and more transfers at pre-arranged price.

https://vivergofuels.com/news/ Perhaps this was a share price catalyst as well

The problem is companies can go down 50pc on profits warnings nowadays. Here we’ve had an uncertain RNS - direction will be found when certainly restored.

you clearly didn't read the link my little cretin